A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome
- Conditions
- Interventions
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 10
- Registration Number
- NCT03992196
- Locations
- 🇺🇸
Rl0007 101, Culver City, California, United States
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
- Conditions
- Interventions
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 200
- Registration Number
- NCT03971422
- Locations
- 🇺🇸
Mg0003 50092, Orange, California, United States
🇺🇸Mg0003 50105, Saint Louis, Missouri, United States
🇮🇹Mg0003 40149, Lazio, Italy
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis
- Conditions
- Interventions
- First Posted Date
- 2019-04-26
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 274
- Registration Number
- NCT03928704
- Locations
- 🇧🇪
As0010 40004, Bruxelles, Belgium
🇺🇸As0010 50060, Upland, California, United States
🇺🇸As0010 50016, Saint Louis, Missouri, United States
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis
- First Posted Date
- 2019-04-26
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 332
- Registration Number
- NCT03928743
- Locations
- 🇫🇷
As0011 40018, Boulogne Billancourt, France
🇯🇵As0011 20032, Suita, Japan
🇵🇱As0011 40039, Wroclaw, Poland
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 400
- Registration Number
- NCT03896581
- Locations
- 🇺🇸
Pa0011 50004, Tustin, California, United States
🇺🇸Pa0011 50035, San Diego, California, United States
🇺🇸Pa0011 50017, Phoenix, Arizona, United States
A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
- Conditions
- Interventions
- First Posted Date
- 2019-03-29
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 852
- Registration Number
- NCT03895203
- Locations
- 🇩🇪
Pa0010 40026, Ratingen, Germany
🇭🇺Pa0010 40030, Eger, Hungary
🇮🇹Pa0010 40084, Catania, Italy
A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)
- Conditions
- Interventions
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 172
- Registration Number
- NCT03766685
- Locations
- 🇺🇸
Dv0002 962, Owensboro, Kentucky, United States
🇨🇦Dv0002 651, Richmond Hill, Canada
🇨🇦Dv0002 670, Windsor, Canada
A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy
- Conditions
- Interventions
- First Posted Date
- 2018-11-14
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 232
- Registration Number
- NCT03739840
- Locations
- 🇧🇬
Ep0092 150, Blagoevgrad, Bulgaria
🇭🇷Ep0092 128, Zagreb, Croatia
🇪🇪Ep0092 276, Tallinn, Estonia
A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause
- Conditions
- Interventions
- First Posted Date
- 2018-11-02
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 23
- Registration Number
- NCT03728933
- Locations
- 🇺🇸
Sp1006 101, Culver City, California, United States
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 1353
- Registration Number
- NCT03598790
- Locations
- 🇺🇸
Ps0014 956, Verona, New Jersey, United States
🇺🇸Ps0014 951, Webster, Texas, United States
🇨🇦Ps0014 659, Calgary, Canada